The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.

· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...

AstraZeneca has a new at-home flu vaccine coming out. When will it arrive and how will it be administered? Here's what to ...

Fewer people came forward for their flu vaccine last year and if the same happens again the UK could be in for a worse winter ...

US's FluMist can now be administered by a healthcare provider or by recipient or caregiver aged 18 or above. India's Nasovac ...

The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...

According to GlobalData, the US vaccination rate for seasonal influenza during the 2023-2024 season was estimated to be 47%, ...

On September 20, 2024, the U.S. Food & Drug Administration (FDA) announced they had approved an at-home nasal spray influenza ...

Stay healthy this flu season. Learn about the CDC’s recommendations for annual influenza vaccinations and how to protect your ...

The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).